Aegera Therapeutics Inc., a Montreal-based drug developer, has held a Cnd$14 first close on its Series C funding round. VenGrowth led the deal, and was joined by return backers GrowthWorks, Business Development Bank of
Aegera Therapeutics Inc., a Montreal-based drug developer, has held a Cnd$14 first close on its Series C funding round. VenGrowth led the deal, and was joined by return backers GrowthWorks, Business Development Bank of
Copyright PEI Media
Not for publication, email or dissemination